Stephen J. Ko, M.D.

  1. Radiation Oncologist
  1. Leon J, Trifiletti DM, Waddle MR, Vallow L, Ko S, May B, Tzou K, Ruiz-Garcia H, Lundy L, Chaichana K, Vibhute P, Peterson JL. Trends in the initial management of vestibular schwannoma in the United States. J Clin Neurosci. 2019 Oct; 68:174-178 Epub 2019 July 16
    View PubMed
  2. Sio TT, Le-Rademacher JG, Leenstra JL, Loprinzi CL, Rine G, Curtis A, Singh AK, Martenson JA Jr, Novotny PJ, Tan AD, Qin R, Ko SJ, Reiter PL, Miller RC. Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical Trial. JAMA. 2019 Apr 16; 321 (15):1481-1490
    View PubMed
  3. Gamez ME, Kraus R, Hinni ML, Moore EJ, Ma DJ, Ko SJ, Rwigema JCM, McGee LA, Halyard MY, Buras MR, Foote RL, Patel SH. Treatment outcomes of squamous cell carcinoma of the oral cavity in young adults. Oral Oncol. 2018 Dec; 87:43-48 Epub 2018 Oct 22
    View PubMed
  4. Lou Y, Dholaria B, Soyano A, Hodge D, Cochuyt J, Manochakian R, Ko SJ, Thomas M, Johnson MM, Patel NM, Miller RC, Adjei AA, Ailawadhi S. Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers. Cancer Med. 2018 Oct; 7 (10):4932-4942 Epub 2018 Sept 02
    View PubMed
  5. Hobbs CJ, Ko SJ, Paryani NN, Accurso JM, Olivier KR, Garces YI, Park SS, Hallemeier CL, Schild SE, Vora SA, Ashman JB, Rule WG, Bowers JR, Heckman MG, Diehl NN, Miller RC. Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic Experience. Mayo Clin Proc Innov Qual Outcomes. 2018 Mar; 2 (1):40-48 Epub 2017 Dec 26
    View PubMed
  6. Hintenlang LL, Miller DH, Kaleem T, Patel N, May BC, Tzou KS, Vallow LA, Buskirk SJ, Miller RC, Ko SJ, Jaeckle KA, Trifiletti DM, Peterson JL. Treatment of a glioblastoma multiforme dural metastasis with stereotactic radiosurgery: A case report and select review of the literature. J Clin Neurosci. 2018 Feb; 48:118-121 Epub 2017 Nov 26
    View PubMed
  7. Patel AB, Tzou KS, Single M, Hollant L, Smart B, Gaines K, Sherman C, Peterson JL, Ko SJ, Vallow LA, Miller RC, Buskirk SJ. Radiation therapy prophylaxis for heterotopic ossification in non-hip sites. Journal of Cancer Therapy. 2017.
  8. Patel AJ, Tzou KS, Heckman MG, Thomas CS, Lee RJ, Paryani N, Peterson JL, Miller RC, Ko SJ, Vallow LA, Buskirk SJ. Estimation of PSA Half-Life Following Salvage Radiation Therapy Journal of Cancer Therapy. 2017.
  9. Gamez ME, Lal D, Halyard MY, Wong WW, Vargas C, Ma D, Ko SJ, Foote RL, Patel SH. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience. Head Neck. 2017 Sep; 39 (9):1819-1824 Epub 2017 May 31
    View PubMed
  10. Habboush Y, Shannon RP, Niazi SK, Hollant L, Single M, Gaines K, Smart B, Chimato NT, Heckman MG, Buskirk SJ, Vallow LA, Tzou KS, Ko SJ, Peterson JL, Biers HA, Day AB, Nelson KA, Sloan JA, Halyard MY, Miller RC. Patient-reported distress and survival among patients receiving definitive radiation therapy. Adv Radiat Oncol. 2017 Apr-Jun; 2 (2):211-219 Epub 2017 Mar 20
    View PubMed
  11. Lee RJ, Tzou KS, Heckman MG, Hobbs CJ, Rawal B, Diehl NN, Peterson JL, Paryani NN, Ko SJ, Daugherty LC, Vallow LA, Wong W, Schild S, Pisansky TM, Buskirk SJ. Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapy. BJU Int. 2016 Aug; 118 (2):236-42 Epub 2015 Aug 22
    View PubMed
  12. King W, Ko S, Miller D. Recurrent High-Grade Invasive Mucoepidermoid Carcinoma of Larynx: A Case Report and Review of the Literature. Rare Tumors. 2016 Jun 28; 8 (2):6204 Epub 2016 June 29
    View PubMed
  13. Curtis KK, Ross HJ, Garrett AL, Jizba TA, Patel AB, Patel SH, Wong WW, Halyard MY, Ko SJ, Kosiorek HE, Foote RL. Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic. Radiat Oncol. 2016 Apr 9; 11:55 Epub 2016 Apr 09
    View PubMed
  14. Miller DH, Peterson JL, Buskirk SJ, Vallow LA, Ta R, Joseph R, Krishna M, Ko SJ, Tzou KS. Management of Metastatic Apocrine Hidradenocarcinoma with Chemotherapy and Radiation. Rare Tumors. 2015 Sep 7; 7 (3):6082 Epub 2015 Oct 05
    View PubMed
  15. Patel SH, Hayden RE, Hinni ML, Wong WW, Foote RL, Milani S, Wu Q, Ko SJ, Halyard MY. Angiosarcoma of the scalp and face: the Mayo Clinic experience. JAMA Otolaryngol Head Neck Surg. 2015 Apr; 141(4):335-40.
    View PubMed
  16. Paryani NN, Peterson JL, Albold C, Taylor SR, Vallow L, Ko SJ, Buskirk SJ. Resident Understanding of ACGME Core Competencies Journal of Nature and Science. 2015; 1(2):e39.
  17. Peterson JL, Buskirk SJ, Heckman MG, Diehl NN, Bernard JR Jr, Tzou KS, Casale HE, Bellefontaine LP, Serago C, Kim S, Vallow LA, Daugherty LC, Ko SJ. Image-guided intensity-modulated radiotherapy for prostate cancer: Dose constraints for the anterior rectal wall to minimize rectal toxicity. Med Dosim. 2014 Spring; 39: (1)12-7.
    View PubMed
  18. Peterson JL, Vallow LA, Johnson DW, Heckman MG, Diehl NN, Smith AA, Tzou KS, Paz-Fumagalli R, Kim S, Ko SJ, Daugherty LC, Kim GP, Brown N, Mori KW, Buskirk SJ. Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patients. Brachytherapy. 2013 Nov-Dec; 12 (6):573-9 Epub 2013 Aug 14
    View PubMed
  19. Kim S, Kim T, Ko SJ, Serago C, Smith A, Vallow LA, Peterson JL, Lee R. Negative margin technique - a novel planning strategy to improve dose conformation in SBRT using dynamic conformal arc delivery. J Appl Clin Med Phys. 2013 Sep 6; 14 (5):79-89 Epub 2013 Sept 06
    View PubMed
  20. Peterson JL, Buskirk SJ, Heckman MG, Parker AS, Diehl NN, Tzou KS, Paryani NN, Ko SJ, Daugherty LC, Vallow LA, Pisansky TM. Evaluation of Serum Calcium as a Predictor of Biochemical Recurrence following Salvage Radiation Therapy for Prostate Cancer. ISRN Oncol. 2013; 2013:239241 Epub 2013 Mar 31
    View PubMed
  21. Heckman MG, Parker AS, Wu KJ, Hilton TW, Ko SJ, Pisansky TM, Schild SE, Khor LY, Hammond EH, Pollack A, Buskirk SJ. Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer. Prostate. 2012 Dec 1; 72 (16):1757-66 Epub 2012 Apr 18
    View PubMed
  22. Panjala C, Nguyen JH, Al-Hajjaj AN, Rosser BA, Nakhleh RE, Bridges MD, Ko SJ, Buskirk SJ, Kim GP, Harnois DM. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma. Liver Transpl. 2012 May; 18(5):594-601.
    View PubMed
  23. Bernard JR, Buskirk SJ, Heckman MG, Diehl NN, Ko SJ, Macdonald OK, Schild SE, Pisansky TM. Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis. Int J Radiat Oncol Biol Phys. 2010 Mar 1; 76(3):735-40. Epub 2009 May 21.
    View PubMed
  24. Peterson JL, Buskirk SJ, Heckman MG, Crook JE, Ko SJ, Wehle MJ, Igel TC, Prussak KA, Pisansky TM. Late toxicity after postprostatectomy salvage radiation therapy. Radiother Oncol. 2009 Nov; 93: (2)203-6.
    View PubMed
  25. Ko SJ, Liao XY, Molloi S, Elmore E, Redpath JL. Neoplastic transformation in vitro after exposure to low doses of mammographic-energy X rays: quantitative and mechanistic aspects. Radiat Res. 2004 Dec; 162(6):646-54.
    View PubMed
  26. Syed AM, Puthawala A, Sharma A, Gamie S, Londrc A, Cherlow JM, Damore SJ, Nazmy N, Sheikh KM, Ko SJ. High-dose-rate brachytherapy in the treatment of carcinoma of the prostate. Cancer Control. 2001 Nov-Dec; 8(6):511-21.
    View PubMed